Blood Collection Market Outlook (2022-2033)

Rising Prevalence of Chronic and Infectious Diseases  

Chronic and infectious disease prevalence is one of the main drivers for revenue growth in the blood collection market. With the ageing population and a growing number of individuals suffering from lifestyle-related health issues (such as diabetes, heart disease and cancer), healthcare providers require testing of blood specimens multiple times over the life cycle of the patient to aid in diagnosing, monitoring, and treating their condition(s). A recent WHO (2024) global health estimate indicates that there are currently approximately 1.3 billion people around the world suffering from chronic diseases, in addition to the millions of annual cases associated with infectious diseases. Thus, increased demand for blood collection due to a growing number of chronically and acutely ill patients supports growth in the blood collection markets who provide hospitals, laboratories and blood banks with ways to efficiently collect specimens for increasing patient testing volumes.

Due to their ongoing expansion in international markets, major healthcare networks (such as Quest Diagnostics, Labcorp, and Roche Diagnostics) have increased demand for advanced blood collection devices to ensure sample integrity and eliminate contamination while increasing workflow efficiency. In addition to providing an automated way of collecting blood, the automated blood collection systems, safety-engineered needles, and customized blood bags are designed specifically for use in high-volume testing environments, making them ideally suited to satisfy the needs of laboratories where speed, accuracy, and safety are top priorities. Unlike traditional manual collection techniques, modern collection methods allow healthcare providers to collect large volumes of samples while still maintaining the quality of those samples, thereby providing healthcare professionals with the ability to perform both everyday diagnostic work and emergency interventions.

Growth of At-Home and Remote Blood Collection

The growth of at-home and remote blood collection represents a major opportunity for blood collection market. Increased adoption of home healthcare, telemedicine, and decentralized clinical testing is leading to demand for blood collection methods that are convenient and friendly to the patients. At-home blood collection devices such as fingerstick kits, microsampling tools, and dried blood spot (DBS) cards, allow patients to take samples without going to hospitals or labs, hence, accessibility and compliance are improved.

Moreover, this trend is also influenced by the increase in the number of people suffering from chronic diseases, aging population, and the necessity of regular diagnostic monitoring. Healthcare providers as well as laboratories gain reduction in operational burden and better workflow efficiency, whereas patients are provided with more convenience and less risk of contracting infections associated with healthcare. What is more, advancements in sample stabilization technologies, logistics, and digital health integration are further improving the dependability and large-scale use of remote blood collection. Consequently, as healthcare systems will more and more turn to patient-centric and decentralized care models, the market will see steady growth in the demand for innovative at-home blood collection products, as well as the creation of new revenue opportunities for the players in the market

The "Blood Collection Market Size and Forecast (2022 - 2033)" report provides a detailed analysis of the market covering below areas:

• Blood Collection market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Blood Collection market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Blood Collection market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the blood collection market
• Detailed company profiles, including SWOT analysis

The Blood Collection Market is segmented geographically into North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America, each exhibiting distinct growth drives and market dynamics. The Asia Pacific Blood Collection Market is projected to expand rapidly during the forecast period, supported by rising healthcare access, growing diagnostic demand, and increased adoption of advanced blood collection technologies. Major countries like China and India are at the forefront, driven by expanding hospital infrastructure, government-driven blood donation initiatives, and increasing prevalence of chronic diseases that require frequent testing.

Demand for blood collection products and services is being considerably driven across the Asia Pacific region by the significant rise in hospital outpatient testing, molecular diagnostics and safety devices usage. Urbanization and the directing of private healthcare networks are advantages for the emerging Southeast Asian and Oceania markets, while the integration of automation and AI-enabled lab systems is at its peak in Japan and South Korea.

North America market is still the leader in blood collection products and services due to the presence of well-established healthcare systems, high volume of diagnostic procedures and strong penetration of advanced safety-engineered collection devices. The United States has the major share and is backed by the highest chronic disease screening, a lot of surgical procedures and the widespread use of automation in clinical laboratories. Nevertheless, Canada and Mexico are also players in the regional growth through their expanding diagnostic testing and hospital services.

The European market is the second largest contributor to the blood collection products segment. The combination of a well-established healthcare system, a high degree of laboratory automation, and the most stringent regulations ensuring the safety and effectiveness of blood collection practices is what keeps Europe so dominant in the blood collection products market. The major countries in this respect are Germany, the UK, France, Italy, and Spain, where the demand is driven mainly by the diagnostics of chronic diseases and blood draws in hospitals.

The Middle East and Africa are slowly but surely coming up the ladder, and the main drivers are increasing healthcare investments and the awareness created by government-sponsored blood donation drives. The primary markets are Saudi Arabia, the UAE, and South Africa, where the growth in demand for diagnostics, safety devices, and better laboratory infrastructure are pushing the market up, though the growth is from a smaller base than in the case of developed regions.   

In South & Central America, emerging healthcare infrastructure, rising insurance penetration, and increasing chronic disease prevalence are enhancing demand for blood collection solutions. Brazil and Mexico are primary contributors, with growing adoption of automated blood collection systems and broader diagnostic testing services improving regional market prospects

• The report includes qualitative and quantitative data in the Blood Collection market across product, method, application, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the Blood Collection market.
• Chapter 3 includes the research methodology of the study.
• Chapter 4 further includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the Blood Collection market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the Blood Collection market scenario, in terms of historical market revenues, and forecast till the year 2031.
• Chapters 7 to 10 cover Blood Collection market segments by product, method, application, end user, and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. They cover the market volume revenue forecast and factors driving the market.
• Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 13 provides detailed profiles of the major companies operating in the Blood Collection market. Companies have been profiled on the basis of their key facts, business descriptions, products and services, financial overview, SWOT analysis, and key developments.
• Chapter 14, i.e., the appendix is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

The Blood Collection market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the air cargo services market are:

• In December 2025, Hims and Hers to Acquire YourBio Health, Pioneer Behind Advanced, Pain-Free Blood Sampling Technology.
• In August 2024, Medical Technology and Devices (MTD) announced the successful closing of the acquisition of Ypsomed’s Pen Needles and Blood Glucose Monitoring Systems (BGM) businesses, a strategic acquisition initially announced at the end of March. This acquisition marks a major step forward in MTD’s mission to provide superior diabetes and obesity care solutions on a global scale.
• In December 2024, GVS S.p.A., a global leader in advanced filtration solutions, announced a binding agreement to acquire Haemonetics Corporation’s Transfusion Medicine business. This acquisition marks a significant milestone for GVS as it strengthens its position in the healthcare filtration sector and expands its global reach.